RPL15

Across TCGA pan-cancer cohorts, RPL15 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated RPL15 data layer compared with 24 for mass-spec protein and 6 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher RPL15 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated RPL15 expression acts as an unfavorable survival marker.

UCEC, GBM, and ESCA are the cancer types where RPL15 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Median	IV	0.225	0.772	<.001	18	view →
GBM	OS	Median	All	0.020	0.416	<.001	12	view →
ESCA	OS	Median	II,III,IV	0.321	0.685	.035	6	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

RPL15–UCEC (OS)

Open the UCEC breakdown →